On June 26, Axinn partner Chad Landmon participated in an AIPLA CLE webinar entitled, "Division of Labor and Divided Infringement: Unified Strategies for Personalized Medicine and other Medical Treatment Inventions?"

Hosted by the American Intellectual Property Law Association, this webinar addressed various practical implications of the test for divided infringement as they relate to personalized medicine and other types of Bio/Pharma patents, and presented possible strategies for drafting claims that are more easily enforced.